Process View
The morphogenetic process that results in flattening of a cell as a consequence of its adhesion to a substrate.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "substrate adhesion dependent cell spreading"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 1.000 | Human | |
FHL2 | four and a half LIM domains 2 | 0.998 | ||
ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.985 | ||
PDIA3 | protein disulfide isomerase family A, member 3 | 0.982 | ||
SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.964 | Mouse | |
FN1 | fibronectin 1 | 0.961 | ||
CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.941 | ||
LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.928 | ||
MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.864 | ||
PXN | paxillin | 0.828 | Human Mouse | |
S100A9 | S100 calcium binding protein A9 | 0.810 | Human | |
PTK2 | PTK2 protein tyrosine kinase 2 | 0.792 | ||
FLNA | filamin A, alpha | 0.785 | ||
ILK | integrin-linked kinase | 0.783 | ||
ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.710 | Human | |
LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.612 | ||
S100A6 | S100 calcium binding protein A6 | 0.590 | Human | |
S100A8 | S100 calcium binding protein A8 | 0.572 | Human | |
EPHA2 | EPH receptor A2 | 0.497 | Human | |
RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.449 | ||
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.432 | ||
RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.414 | Human | |
PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.410 | ||
ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.366 | ||
ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.346 | Human | |
FYN | FYN oncogene related to SRC, FGR, YES | 0.331 | ||
VCL | vinculin | 0.299 | ||
TLN1 | talin 1 | 0.278 | Human | |
CLASP1 | cytoplasmic linker associated protein 1 | 0.275 | ||
FLNB | filamin B, beta | 0.270 | ||
S100A4 | S100 calcium binding protein A4 | 0.270 | Human | |
LAMB1 | laminin, beta 1 | 0.238 | ||
ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.221 | Human | |
COL7A1 | collagen, type VII, alpha 1 | 0.216 | ||
LIMS1 | LIM and senescent cell antigen-like domains 1 | 0.209 | ||
GAS6 | growth arrest-specific 6 | 0.196 | ||
PARVA | parvin, alpha | 0.193 | ||
S100A2 | S100 calcium binding protein A2 | 0.192 | Human | |
ENG | endoglin | 0.183 | ||
ANGPT2 | angiopoietin 2 | 0.181 | ||
CALD1 | caldesmon 1 | 0.168 | ||
ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.159 | ||
ANXA2 | annexin A2 | 0.152 | ||
ZYX | zyxin | 0.134 | ||
EFNA1 | ephrin-A1 | 0.129 | ||
LMNA | lamin A/C | 0.125 | ||
HP | haptoglobin | 0.124 | ||
EFNA5 | ephrin-A5 | 0.123 | Human | |
THBS1 | thrombospondin 1 | 0.120 | ||
APOC1 | apolipoprotein C-I | 0.110 | ||
AREG | amphiregulin | 0.110 | ||
YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide | 0.108 | ||
ITGA6 | integrin, alpha 6 | 0.105 | Human | |
VCAM1 | vascular cell adhesion molecule 1 | 0.104 | ||
PAK1 | p21 protein (Cdc42/Rac)-activated kinase 1 | 0.098 | ||
MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.094 | ||
NCK2 | NCK adaptor protein 2 | 0.090 | ||
ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.090 | Human | |
LTBP2 | latent transforming growth factor beta binding protein 2 | 0.085 | ||
ANGPT1 | angiopoietin 1 | 0.078 | ||
LPXN | leupaxin | 0.076 | Human | |
MSN | moesin | 0.075 | ||
GRB7 | growth factor receptor-bound protein 7 | 0.075 | ||
ANXA1 | annexin A1 | 0.070 | ||
TCF4 | transcription factor 4 | 0.068 | ||
LAMB3 | laminin, beta 3 | 0.066 | Human | |
STX4 | syntaxin 4 | 0.066 | ||
ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.066 | Human | |
EPHA7 | EPH receptor A7 | 0.065 | Human | |
LAMC2 | laminin, gamma 2 | 0.065 | Human | |
ZNF746 | zinc finger protein 746 | 0.062 | ||
CD63 | CD63 molecule | 0.058 | ||
AHNAK | AHNAK nucleoprotein | 0.057 | ||
TENC1 | tensin like C1 domain containing phosphatase (tensin 2) | 0.056 | ||
RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.055 | ||
TRIP6 | thyroid hormone receptor interactor 6 | 0.054 | ||
PLEC | plectin | 0.054 | ||
RHOC | ras homolog gene family, member C | 0.051 | ||
ITGA4 | integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) | 0.050 | ||
ANXA5 | annexin A5 | 0.050 | ||
CBLB | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | 0.050 | ||
EPHA3 | EPH receptor A3 | 0.048 | Human | |
GAST | gastrin | 0.048 | ||
RRAS | related RAS viral (r-ras) oncogene homolog | 0.046 | ||
APP | amyloid beta (A4) precursor protein | 0.045 | ||
EPS8 | epidermal growth factor receptor pathway substrate 8 | 0.045 | ||
ITGB4 | integrin, beta 4 | 0.045 | Human | |
ITGA7 | integrin, alpha 7 | 0.045 | Human | |
ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.043 | ||
KRT17 | keratin 17 | 0.043 | ||
SORBS3 | sorbin and SH3 domain containing 3 | 0.042 | ||
TGFBR1 | transforming growth factor, beta receptor 1 | 0.042 | ||
TGFB2 | transforming growth factor, beta 2 | 0.041 | ||
ALB | albumin | 0.041 | ||
CLDN1 | claudin 1 | 0.041 | ||
COL17A1 | collagen, type XVII, alpha 1 | 0.040 | ||
CTGF | connective tissue growth factor | 0.040 | ||
ITGB5 | integrin, beta 5 | 0.039 | Human | |
FAF1 | Fas (TNFRSF6) associated factor 1 | 0.038 | ||
PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.038 | ||
TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.038 | ||
MPRIP | myosin phosphatase Rho interacting protein | 0.038 | ||
BCAM | basal cell adhesion molecule (Lutheran blood group) | 0.038 | ||
EZR | ezrin | 0.037 | ||
CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.036 | ||
S100B | S100 calcium binding protein B | 0.036 | Human | |
S100A1 | S100 calcium binding protein A1 | 0.036 | Human | |
PTN | pleiotrophin | 0.035 | ||
TEK | TEK tyrosine kinase, endothelial | 0.035 | ||
HOXA1 | homeobox A1 | 0.034 | ||
EMP3 | epithelial membrane protein 3 | 0.034 | ||
MYO10 | myosin X | 0.034 | ||
RANBP9 | RAN binding protein 9 | 0.034 | ||
CLDN7 | claudin 7 | 0.034 | ||
LCAT | lecithin-cholesterol acyltransferase | 0.034 | ||
MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.034 | ||
ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | 0.034 | ||
CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 | 0.033 | ||
WWTR1 | WW domain containing transcription regulator 1 | 0.033 | ||
CFB | complement factor B | 0.033 | ||
CD9 | CD9 molecule | 0.033 | ||
CYTH1 | cytohesin 1 | 0.032 | ||
NOTCH3 | notch 3 | 0.032 | ||
S100A11 | S100 calcium binding protein A11 | 0.032 | Human | |
RAI14 | retinoic acid induced 14 | 0.032 | ||
NRP1 | neuropilin 1 | 0.032 | ||
RHOU | ras homolog gene family, member U | 0.031 | ||
COL18A1 | collagen, type XVIII, alpha 1 | 0.031 | ||
SELPLG | selectin P ligand | 0.031 | ||
DEF6 | differentially expressed in FDCP 6 homolog (mouse) | 0.030 | ||
KSR1 | kinase suppressor of ras 1 | 0.029 | ||
FKBP4 | FK506 binding protein 4, 59kDa | 0.029 | ||
TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.029 | ||
TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.029 | Human | |
FHL3 | four and a half LIM domains 3 | 0.029 | Human | |
COL1A1 | collagen, type I, alpha 1 | 0.029 | ||
PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.029 | ||
DOCK1 | dedicator of cytokinesis 1 | 0.028 | ||
PLAUR | plasminogen activator, urokinase receptor | 0.028 | ||
CDH3 | cadherin 3, type 1, P-cadherin (placental) | 0.028 | ||
FBN1 | fibrillin 1 | 0.027 | ||
CDC42EP3 | CDC42 effector protein (Rho GTPase binding) 3 | 0.027 | ||
TGFBI | transforming growth factor, beta-induced, 68kDa | 0.027 | ||
AGER | advanced glycosylation end product-specific receptor | 0.026 | ||
MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.026 | ||
SOX9 | SRY (sex determining region Y)-box 9 | 0.026 | ||
RASAL2 | RAS protein activator like 2 | 0.026 | ||
SH3BP4 | SH3-domain binding protein 4 | 0.026 | ||
MYLK | myosin light chain kinase | 0.026 | ||
GIT1 | G protein-coupled receptor kinase interacting ArfGAP 1 | 0.026 | ||
S100A10 | S100 calcium binding protein A10 | 0.026 | ||
SEMA3F | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F | 0.025 | ||
RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.025 | ||
SDCBP | syndecan binding protein (syntenin) | 0.025 | ||
ADAM9 | ADAM metallopeptidase domain 9 | 0.025 | ||
CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.025 | ||
ARAF | v-raf murine sarcoma 3611 viral oncogene homolog | 0.025 | ||
MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.025 | ||
FKBP1A | FK506 binding protein 1A, 12kDa | 0.025 | ||
LAMA5 | laminin, alpha 5 | 0.025 | ||
RHOA | ras homolog gene family, member A | 0.025 | ||
EPHB4 | EPH receptor B4 | 0.025 | Human | |
PAK2 | p21 protein (Cdc42/Rac)-activated kinase 2 | 0.025 | ||
CAPG | capping protein (actin filament), gelsolin-like | 0.024 | ||
APOC3 | apolipoprotein C-III | 0.024 | ||
TBC1D1 | TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 | 0.024 | ||
CLDN5 | claudin 5 | 0.024 | ||
DAG1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) | 0.024 | ||
STAB1 | stabilin 1 | 0.024 | ||
EGFR | epidermal growth factor receptor | 0.023 | ||
FMNL1 | formin-like 1 | 0.023 | ||
YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.023 | ||
SNAP23 | synaptosomal-associated protein, 23kDa | 0.023 | ||
EFNB2 | ephrin-B2 | 0.023 | ||
MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.023 | ||
HSPG2 | heparan sulfate proteoglycan 2 | 0.022 | ||
SNAPIN | SNAP-associated protein | 0.022 | ||
CLDN4 | claudin 4 | 0.022 | ||
WASL | Wiskott-Aldrich syndrome-like | 0.022 | ||
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.022 | ||
S100P | S100 calcium binding protein P | 0.022 | Human | |
TTR | transthyretin | 0.022 | ||
PTPN21 | protein tyrosine phosphatase, non-receptor type 21 | 0.022 | ||
GSN | gelsolin | 0.022 | ||
SAMD4A | sterile alpha motif domain containing 4A | 0.022 | ||
SPRR2A | small proline-rich protein 2A | 0.021 | ||
LCN2 | lipocalin 2 | 0.021 | ||
MAP4K4 | mitogen-activated protein kinase kinase kinase kinase 4 | 0.021 | ||
PCOLCE | procollagen C-endopeptidase enhancer | 0.021 | ||
CTTN | cortactin | 0.021 | ||
RBMS3 | RNA binding motif, single stranded interacting protein 3 | 0.021 | ||
PALLD | palladin, cytoskeletal associated protein | 0.021 | ||
TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.021 | Human | |
TGFB1 | transforming growth factor, beta 1 | 0.021 | ||
JAG1 | jagged 1 | 0.020 | ||
PICALM | phosphatidylinositol binding clathrin assembly protein | 0.020 | ||
IGFBP3 | insulin-like growth factor binding protein 3 | 0.020 | ||
SMAD2 | SMAD family member 2 | 0.020 | ||
COL5A2 | collagen, type V, alpha 2 | 0.020 | ||
GJB3 | gap junction protein, beta 3, 31kDa | 0.020 | ||
CRIM1 | cysteine rich transmembrane BMP regulator 1 (chordin-like) | 0.020 | ||
KRT6B | keratin 6B | 0.020 | ||
NOTCH2 | notch 2 | 0.020 | ||
FRMD6 | FERM domain containing 6 | 0.020 | ||
NDP | Norrie disease (pseudoglioma) | 0.020 | ||
CSTA | cystatin A (stefin A) | 0.019 | ||
PI3 | peptidase inhibitor 3, skin-derived | 0.019 | ||
ANGPTL4 | angiopoietin-like 4 | 0.019 | ||
MUC1 | mucin 1, cell surface associated | 0.019 | ||
COL5A1 | collagen, type V, alpha 1 | 0.019 | ||
GPRASP2 | G protein-coupled receptor associated sorting protein 2 | 0.019 | ||
CNN1 | calponin 1, basic, smooth muscle | 0.019 | ||
CD97 | CD97 molecule | 0.019 | ||
CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.019 | ||
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.019 | ||
LAMC3 | laminin, gamma 3 | 0.019 | Human | |
PTPRC | protein tyrosine phosphatase, receptor type, C | 0.019 | ||
PHF21A | PHD finger protein 21A | 0.019 | ||
PLAT | plasminogen activator, tissue | 0.019 | ||
RDX | radixin | 0.019 | ||
ACVR1 | activin A receptor, type I | 0.019 | ||
FSTL1 | follistatin-like 1 | 0.019 | ||
HSPB1 | heat shock 27kDa protein 1 | 0.019 | ||
LRP1 | low density lipoprotein receptor-related protein 1 | 0.019 | ||
APOA2 | apolipoprotein A-II | 0.019 | ||
ITGAX | integrin, alpha X (complement component 3 receptor 4 subunit) | 0.019 | Human | |
BMP1 | bone morphogenetic protein 1 | 0.018 | ||
A2M | alpha-2-macroglobulin | 0.018 | ||
PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.018 | ||
SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0.018 | ||
CAPN2 | calpain 2, (m/II) large subunit | 0.018 | ||
APOC2 | apolipoprotein C-II | 0.018 | ||
NCL | nucleolin | 0.018 | ||
SRI | sorcin | 0.018 | ||
TLN2 | talin 2 | 0.018 | Human | |
FNDC3B | fibronectin type III domain containing 3B | 0.018 | Mouse | |
ERC1 | ELKS/RAB6-interacting/CAST family member 1 | 0.018 | ||
PARVB | parvin, beta | 0.018 | Human | |
TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.018 | ||
LPP | LIM domain containing preferred translocation partner in lipoma | 0.018 | ||
COTL1 | coactosin-like 1 (Dictyostelium) | 0.018 | ||
GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 0.018 | ||
RBMS1 | RNA binding motif, single stranded interacting protein 1 | 0.018 | ||
NPR1 | natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) | 0.018 | ||
NRP2 | neuropilin 2 | 0.018 | ||
ITGB8 | integrin, beta 8 | 0.017 | Human | |
COL4A2 | collagen, type IV, alpha 2 | 0.017 | ||
NCF2 | neutrophil cytosolic factor 2 | 0.017 | ||
CORO1A | coronin, actin binding protein, 1A | 0.017 | ||
LAMA3 | laminin, alpha 3 | 0.017 | Human | |
PLSCR3 | phospholipid scramblase 3 | 0.017 | ||
GIT2 | G protein-coupled receptor kinase interacting ArfGAP 2 | 0.017 | ||
TRIM29 | tripartite motif containing 29 | 0.017 | ||
FKBP9 | FK506 binding protein 9, 63 kDa | 0.017 | ||
SERPINB5 | serpin peptidase inhibitor, clade B (ovalbumin), member 5 | 0.017 | ||
MFAP4 | microfibrillar-associated protein 4 | 0.017 | ||
HIPK3 | homeodomain interacting protein kinase 3 | 0.017 | ||
JUP | junction plakoglobin | 0.017 | ||
DLC1 | deleted in liver cancer 1 | 0.017 | ||
CDK11B | cyclin-dependent kinase 11B | 0.017 | ||
ATXN1 | ataxin 1 | 0.017 | ||
TM4SF1 | transmembrane 4 L six family member 1 | 0.016 | ||
TIAM1 | T-cell lymphoma invasion and metastasis 1 | 0.016 | ||
COL12A1 | collagen, type XII, alpha 1 | 0.016 | ||
ARHGEF2 | Rho/Rac guanine nucleotide exchange factor (GEF) 2 | 0.016 | ||
PDLIM4 | PDZ and LIM domain 4 | 0.016 | ||
VIM | vimentin | 0.016 | ||
SORBS2 | sorbin and SH3 domain containing 2 | 0.016 | ||
NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.016 | ||
FASLG | Fas ligand (TNF superfamily, member 6) | 0.016 | ||
EXT1 | exostosin 1 | 0.016 | ||
FES | feline sarcoma oncogene | 0.016 | ||
SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.016 | ||
ITGB6 | integrin, beta 6 | 0.016 | Human | |
SH3BGRL3 | SH3 domain binding glutamic acid-rich protein like 3 | 0.016 | ||
TMEM108 | transmembrane protein 108 | 0.016 | ||
S100A14 | S100 calcium binding protein A14 | 0.016 | ||
FAM82A2 | family with sequence similarity 82, member A2 | 0.016 | ||
TAGLN | transgelin | 0.016 | ||
ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.016 | ||
SEMA3C | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C | 0.016 | ||
CD34 | CD34 molecule | 0.015 | ||
CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.015 | ||
LRP6 | low density lipoprotein receptor-related protein 6 | 0.015 | ||
MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.015 | ||
IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.015 | ||
ADAM17 | ADAM metallopeptidase domain 17 | 0.015 | ||
CLIC4 | chloride intracellular channel 4 | 0.015 | ||
KRT5 | keratin 5 | 0.015 | ||
LAMB2 | laminin, beta 2 (laminin S) | 0.015 | Human | |
LPAR1 | lysophosphatidic acid receptor 1 | 0.015 | ||
MYOF | myoferlin | 0.015 | ||
NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.015 | ||
PHLDB1 | pleckstrin homology-like domain, family B, member 1 | 0.015 | ||
MALL | mal, T-cell differentiation protein-like | 0.015 | ||
RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.015 | ||
S100A12 | S100 calcium binding protein A12 | 0.015 | Human | |
KRT16 | keratin 16 | 0.015 | ||
ICAM3 | intercellular adhesion molecule 3 | 0.014 | ||
FERMT2 | fermitin family member 2 | 0.014 | Human Mouse | |
ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.014 | Human | |
ANGPTL2 | angiopoietin-like 2 | 0.014 | ||
LGALS3 | lectin, galactoside-binding, soluble, 3 | 0.014 | ||
LAMA4 | laminin, alpha 4 | 0.014 | Human | |
SFRP1 | secreted frizzled-related protein 1 | 0.014 | ||
RASSF8 | Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 | 0.014 | ||
UBE2R2 | ubiquitin-conjugating enzyme E2R 2 | 0.014 | ||
ABI2 | abl-interactor 2 | 0.014 | ||
MST1R | macrophage stimulating 1 receptor (c-met-related tyrosine kinase) | 0.014 | ||
F2RL1 | coagulation factor II (thrombin) receptor-like 1 | 0.014 | ||
DARC | Duffy blood group, chemokine receptor | 0.014 | ||
PRKCE | protein kinase C, epsilon | 0.014 | ||
MCAM | melanoma cell adhesion molecule | 0.014 | ||
LST1 | leukocyte specific transcript 1 | 0.014 | ||
EFNB1 | ephrin-B1 | 0.014 | Human | |
EMP1 | epithelial membrane protein 1 | 0.014 | ||
SMARCB1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 0.014 | ||
KIF1C | kinesin family member 1C | 0.014 | Human | |
VAV1 | vav 1 guanine nucleotide exchange factor | 0.014 | ||
KIAA0930 | KIAA0930 | 0.014 | ||
RFK | riboflavin kinase | 0.014 | ||
HECTD3 | HECT domain containing 3 | 0.014 | ||
CCNY | cyclin Y | 0.014 | ||
NID1 | nidogen 1 | 0.014 | ||
COL4A1 | collagen, type IV, alpha 1 | 0.014 | ||
LNX1 | ligand of numb-protein X 1 | 0.014 | ||
MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.014 | ||
SNAI2 | snail homolog 2 (Drosophila) | 0.014 | ||
PPFIBP1 | PTPRF interacting protein, binding protein 1 (liprin beta 1) | 0.014 | ||
EFEMP1 | EGF containing fibulin-like extracellular matrix protein 1 | 0.014 | ||
BAIAP2 | BAI1-associated protein 2 | 0.014 | ||
DOCK8 | dedicator of cytokinesis 8 | 0.013 | ||
KRT7 | keratin 7 | 0.013 | ||
CSPG4 | chondroitin sulfate proteoglycan 4 | 0.013 | ||
TFPI | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | 0.013 | ||
EMCN | endomucin | 0.013 | ||
FXYD5 | FXYD domain containing ion transport regulator 5 | 0.013 | ||
CD151 | CD151 molecule (Raph blood group) | 0.013 | ||
NOS3 | nitric oxide synthase 3 (endothelial cell) | 0.013 | ||
IGF1R | insulin-like growth factor 1 receptor | 0.013 | ||
DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.013 | ||
PLS3 | plastin 3 | 0.013 | ||
DCBLD2 | discoidin, CUB and LCCL domain containing 2 | 0.013 | ||
SFN | stratifin | 0.013 | ||
SMAD6 | SMAD family member 6 | 0.013 | ||
LMCD1 | LIM and cysteine-rich domains 1 | 0.013 | ||
KLC2 | kinesin light chain 2 | 0.013 | ||
HMGA2 | high mobility group AT-hook 2 | 0.013 | ||
RSU1 | Ras suppressor protein 1 | 0.013 | ||
MMRN2 | multimerin 2 | 0.013 | ||
GAS7 | growth arrest-specific 7 | 0.013 | ||
PHC2 | polyhomeotic homolog 2 (Drosophila) | 0.013 | ||
SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 | 0.013 | ||
PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.013 | ||
PSG5 | pregnancy specific beta-1-glycoprotein 5 | 0.013 | ||
ARHGEF6 | Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 | 0.013 | Human | |
FGA | fibrinogen alpha chain | 0.013 | ||
NOTCH4 | notch 4 | 0.013 | ||
ATP5A1 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle | 0.013 | ||
ITGA8 | integrin, alpha 8 | 0.013 | ||
CSF1R | colony stimulating factor 1 receptor | 0.013 | ||
KRT23 | keratin 23 (histone deacetylase inducible) | 0.013 | ||
HDGF | hepatoma-derived growth factor | 0.013 | ||
CYTH4 | cytohesin 4 | 0.013 | ||
TWF2 | twinfilin, actin-binding protein, homolog 2 (Drosophila) | 0.013 | ||
BMP4 | bone morphogenetic protein 4 | 0.013 | ||
AR | androgen receptor | 0.013 | ||
ITGB1BP1 | integrin beta 1 binding protein 1 | 0.012 | ||
MYH11 | myosin, heavy chain 11, smooth muscle | 0.012 | ||
PTPRA | protein tyrosine phosphatase, receptor type, A | 0.012 | ||
CREBBP | CREB binding protein | 0.012 | ||
PRSS23 | protease, serine, 23 | 0.012 | ||
ITGA1 | integrin, alpha 1 | 0.012 | Human | |
OSMR | oncostatin M receptor | 0.012 | ||
SRPX | sushi-repeat containing protein, X-linked | 0.012 | ||
ZNF426 | zinc finger protein 426 | 0.012 | ||
ACTA2 | actin, alpha 2, smooth muscle, aorta | 0.012 | ||
SMCR7L | Smith-Magenis syndrome chromosome region, candidate 7-like | 0.012 | ||
TAX1BP3 | Tax1 (human T-cell leukemia virus type I) binding protein 3 | 0.012 | ||
SLIT3 | slit homolog 3 (Drosophila) | 0.012 | ||
FGFBP1 | fibroblast growth factor binding protein 1 | 0.012 | ||
COL4A6 | collagen, type IV, alpha 6 | 0.012 | ||
PTHLH | parathyroid hormone-like hormone | 0.012 | ||
TINAGL1 | tubulointerstitial nephritis antigen-like 1 | 0.012 | ||
SLIT2 | slit homolog 2 (Drosophila) | 0.012 | ||
NKG7 | natural killer cell group 7 sequence | 0.012 | ||
PTRF | polymerase I and transcript release factor | 0.012 | ||
RASL12 | RAS-like, family 12 | 0.012 | ||
WIPF1 | WAS/WASL interacting protein family, member 1 | 0.012 | ||
SDC1 | syndecan 1 | 0.012 | ||
IGFBP5 | insulin-like growth factor binding protein 5 | 0.012 | ||
COL16A1 | collagen, type XVI, alpha 1 | 0.012 | ||
ANXA3 | annexin A3 | 0.012 | ||
ST13 | suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) | 0.012 | ||
PALM | paralemmin | 0.012 | ||
YAP1 | Yes-associated protein 1 | 0.012 | ||
SDC2 | syndecan 2 | 0.012 | ||
PHLDB2 | pleckstrin homology-like domain, family B, member 2 | 0.012 | ||
NPNT | nephronectin | 0.012 | ||
LHFP | lipoma HMGIC fusion partner | 0.012 | ||
ANGPT4 | angiopoietin 4 | 0.012 | ||
LAPTM5 | lysosomal protein transmembrane 5 | 0.012 | ||
TXNDC2 | thioredoxin domain containing 2 (spermatozoa) | 0.012 | ||
MYO1F | myosin IF | 0.012 | ||
LEPREL1 | leprecan-like 1 | 0.012 | ||
MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.012 | ||
TMC6 | transmembrane channel-like 6 | 0.012 | ||
LTBP1 | latent transforming growth factor beta binding protein 1 | 0.012 | ||
DST | dystonin | 0.012 | ||
ARHGAP9 | Rho GTPase activating protein 9 | 0.012 | ||
FAT1 | FAT tumor suppressor homolog 1 (Drosophila) | 0.012 | ||
AGRN | agrin | 0.012 | ||
EDN1 | endothelin 1 | 0.012 | ||
EFEMP2 | EGF containing fibulin-like extracellular matrix protein 2 | 0.012 | ||
SMO | smoothened homolog (Drosophila) | 0.012 | ||
CD300A | CD300a molecule | 0.011 | ||
GPLD1 | glycosylphosphatidylinositol specific phospholipase D1 | 0.011 | ||
CARD10 | caspase recruitment domain family, member 10 | 0.011 | ||
CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | 0.011 | ||
KIF21A | kinesin family member 21A | 0.011 | ||
INHBA | inhibin, beta A | 0.011 | ||
FYB | FYN binding protein | 0.011 | ||
IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.011 | ||
KIF1B | kinesin family member 1B | 0.011 | Human | |
EFS | embryonal Fyn-associated substrate | 0.011 | ||
SSPN | sarcospan (Kras oncogene-associated gene) | 0.011 | ||
EPB41L3 | erythrocyte membrane protein band 4.1-like 3 | 0.011 | ||
ITIH5 | inter-alpha (globulin) inhibitor H5 | 0.011 | ||
S100A3 | S100 calcium binding protein A3 | 0.011 | Human | |
CSRP1 | cysteine and glycine-rich protein 1 | 0.011 | ||
NFIB | nuclear factor I/B | 0.011 | ||
IRF6 | interferon regulatory factor 6 | 0.011 | ||
TNC | tenascin C | 0.011 | Human | |
PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.011 | ||
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.011 | ||
ICAM2 | intercellular adhesion molecule 2 | 0.011 | ||
ADAM19 | ADAM metallopeptidase domain 19 | 0.011 | ||
GPSM3 | G-protein signaling modulator 3 | 0.011 | ||
CD44 | CD44 molecule (Indian blood group) | 0.011 | ||
LOXL2 | lysyl oxidase-like 2 | 0.011 | ||
CSNK1D | casein kinase 1, delta | 0.011 | ||
S100A7 | S100 calcium binding protein A7 | 0.011 | ||
SH3BP2 | SH3-domain binding protein 2 | 0.011 | ||
COL8A1 | collagen, type VIII, alpha 1 | 0.011 | ||
SDC4 | syndecan 4 | 0.011 | ||
PAPSS2 | 3'-phosphoadenosine 5'-phosphosulfate synthase 2 | 0.011 | ||
INHBB | inhibin, beta B | 0.011 | ||
F3 | coagulation factor III (thromboplastin, tissue factor) | 0.011 | ||
INF2 | inverted formin, FH2 and WH2 domain containing | 0.011 | ||
F7 | coagulation factor VII (serum prothrombin conversion accelerator) | 0.011 | ||
PLOD3 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 | 0.011 | ||
SIPA1 | signal-induced proliferation-associated 1 | 0.011 | ||
FAM129B | family with sequence similarity 129, member B | 0.011 | ||
ASAP2 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 | 0.011 | ||
RASGRP2 | RAS guanyl releasing protein 2 (calcium and DAG-regulated) | 0.011 | ||
SHANK3 | SH3 and multiple ankyrin repeat domains 3 | 0.011 | ||
MYL9 | myosin, light chain 9, regulatory | 0.011 | ||
CDC42EP1 | CDC42 effector protein (Rho GTPase binding) 1 | 0.011 | ||
HAAO | 3-hydroxyanthranilate 3,4-dioxygenase | 0.011 | ||
SLPI | secretory leukocyte peptidase inhibitor | 0.011 | ||
FAM114A1 | family with sequence similarity 114, member A1 | 0.011 | ||
GNG12 | guanine nucleotide binding protein (G protein), gamma 12 | 0.011 | ||
MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0.011 | ||
CNN3 | calponin 3, acidic | 0.011 | ||
AQP1 | aquaporin 1 (Colton blood group) | 0.011 | ||
DCBLD1 | discoidin, CUB and LCCL domain containing 1 | 0.011 | ||
LTBP4 | latent transforming growth factor beta binding protein 4 | 0.011 | ||
HCLS1 | hematopoietic cell-specific Lyn substrate 1 | 0.011 | ||
NUAK1 | NUAK family, SNF1-like kinase, 1 | 0.011 | ||
ARHGEF40 | Rho guanine nucleotide exchange factor (GEF) 40 | 0.011 | ||
SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.011 | ||
MICALL1 | MICAL-like 1 | 0.011 | ||
OCRL | oculocerebrorenal syndrome of Lowe | 0.011 | ||
CLEC4M | C-type lectin domain family 4, member M | 0.011 | ||
POSTN | periostin, osteoblast specific factor | 0.011 | ||
JAG2 | jagged 2 | 0.011 | ||
SEPT10 | septin 10 | 0.011 | ||
ASAH1 | N-acylsphingosine amidohydrolase (acid ceramidase) 1 | 0.011 | ||
RBPMS | RNA binding protein with multiple splicing | 0.010 | ||
NCKIPSD | NCK interacting protein with SH3 domain | 0.010 | ||
RARB | retinoic acid receptor, beta | 0.010 | ||
ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.010 | ||
FILIP1L | filamin A interacting protein 1-like | 0.010 | ||
RGS12 | regulator of G-protein signaling 12 | 0.010 | ||
MAP3K11 | mitogen-activated protein kinase kinase kinase 11 | 0.010 | ||
CDCP1 | CUB domain containing protein 1 | 0.010 | ||
TPM1 | tropomyosin 1 (alpha) | 0.010 | ||
PLD2 | phospholipase D2 | 0.010 | ||
RGS19 | regulator of G-protein signaling 19 | 0.010 | ||
EPS8L2 | EPS8-like 2 | 0.010 | ||
PXDN | peroxidasin homolog (Drosophila) | 0.010 | ||
VEGFC | vascular endothelial growth factor C | 0.010 | ||
WIPI1 | WD repeat domain, phosphoinositide interacting 1 | 0.010 | ||
MAGEA11 | melanoma antigen family A, 11 | 0.010 | ||
MYO1C | myosin IC | 0.010 | ||
VWF | von Willebrand factor | 0.010 | ||
HSPB6 | heat shock protein, alpha-crystallin-related, B6 | 0.010 | ||
KIF5B | kinesin family member 5B | 0.010 | ||
FBLIM1 | filamin binding LIM protein 1 | 0.010 | ||
ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.010 | ||
RBM11 | RNA binding motif protein 11 | 0.010 | ||
PF4 | platelet factor 4 | 0.010 | ||
DDR1 | discoidin domain receptor tyrosine kinase 1 | 0.010 | ||
GJA4 | gap junction protein, alpha 4, 37kDa | 0.010 | ||
P2RX7 | purinergic receptor P2X, ligand-gated ion channel, 7 | 0.010 | ||
AQP3 | aquaporin 3 (Gill blood group) | 0.010 | ||
SORBS1 | sorbin and SH3 domain containing 1 | 0.010 | ||
PDGFC | platelet derived growth factor C | 0.010 | ||
EPHB6 | EPH receptor B6 | 0.010 | Human |